These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1349507)

  • 21. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM; Woerner M; Lieberman J
    Psychopharmacology Suppl; 1985; 2():72-8. PubMed ID: 2860662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.
    Yassa R; Nastase C; Dupont D; Thibeau M
    Am J Psychiatry; 1992 Sep; 149(9):1206-11. PubMed ID: 1354413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.
    Jeste DV; Caligiuri MP; Paulsen JS; Heaton RK; Lacro JP; Harris MJ; Bailey A; Fell RL; McAdams LA
    Arch Gen Psychiatry; 1995 Sep; 52(9):756-65. PubMed ID: 7654127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
    Raja M; Azzoni A
    Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients.
    Jeste DV; Lacro JP; Bailey A; Rockwell E; Harris MJ; Caligiuri MP
    J Am Geriatr Soc; 1999 Jun; 47(6):716-9. PubMed ID: 10366172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive dyskinesia and psychotropic drug history.
    Simpson GM; Varga E; Lee JH; Zoubok B
    Psychopharmacology (Berl); 1978 Jul; 58(2):117-24. PubMed ID: 28544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
    Woods SW; Morgenstern H; Saksa JR; Walsh BC; Sullivan MC; Money R; Hawkins KA; Gueorguieva RV; Glazer WM
    J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent tardive dyskinesia: demographic and pharmacological risk factors.
    Muscettola G; Pampallona S; Barbato G; Casiello M; Bollini P
    Acta Psychiatr Scand; 1993 Jan; 87(1):29-36. PubMed ID: 8093821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescents on neuroleptic medication: is this population at risk for tardive dyskinesia?
    McDermid SA; Hood J; Bockus S; D'Alessandro E
    Can J Psychiatry; 1998 Aug; 43(6):629-31. PubMed ID: 9729692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course.
    Eberhard J; Lindström E; Levander S
    Int Clin Psychopharmacol; 2006 Jan; 21(1):35-42. PubMed ID: 16317315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
    Ganzini L; Heintz RT; Hoffman WF; Casey DE
    Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trend on the prevalence of tardive dyskinesia in Japan.
    Itoh H; Fujii Y; Kamisada M; Kamishima K; Koga Y; Masuda Y; Miura S; Nabeta Y; Nakano Y; Ogita K
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):39-49. PubMed ID: 6145187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.
    Blumberger DM; Mulsant BH; Kanellopoulos D; Whyte EM; Rothschild AJ; Flint AJ; Meyers BS
    J Clin Psychopharmacol; 2013 Jun; 33(3):391-7. PubMed ID: 23609383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of tardive dyskinesia in Japan.
    Inada T; Ohnishi K; Kamisada M; Matsuda G; Tajima O; Yanagisawa Y; Hashiguchi K; Shima S; Oh-e Y; Masuda Y
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(4-5):250-4. PubMed ID: 1675874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia in India: a prevalence study.
    Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Vahora SA; Thatte S; Vevaina T; Bharadwaj J
    J Clin Psychopharmacol; 1982 Oct; 2(5):341-4. PubMed ID: 6127352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
    Lerner V; Miodownik C; Kaptsan A; Bersudsky Y; Libov I; Sela BA; Witztum E
    J Clin Psychiatry; 2007 Nov; 68(11):1648-54. PubMed ID: 18052557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.